FFPE样本通过DEPArray NxT系统分离纯肿瘤细胞和基质细胞，结合shallow WGS和靶向基因 panel分析，成功检测到sCNA和突变，发现PIK3CA ...

肾上腺皮质癌（ACC）是一种罕见且侵袭性强的肿瘤，其循环肿瘤细胞（CTC）的检测对早期诊断和监测微小残留疾病至关重要。本研究提出了一种新型CTC检测方法，结合Parsortix?系统进行大小和机械特性富集，并通过DEPArray?技术利用核标志物SF1免疫荧光染色进行单 ...

The DEPArray™ Kits streamline and optimize the analysis of FFPE samples by providing DEPArray™ users a fast and easy workflow, for a precise genetic analysis on pure cancer and stromal cell ...

Menarini Silicon Biosystems Spa, Castel Maggiore, Italy. An increasing body of evidence demonstrates that intra-tumor heterogeneity (ITH), resulting from subclonal branch alterations arising during ...

Collecting tissue for research purposes: A survey of 16 institutions in the Translational Breast Cancer Research Consortium (TBCRC). This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting ...

Using the innovative DEPArray™ technology, scientists at Silicon Biosystems, a Bologna (Italy) and San Diego (CA, USA) based biotech company, were able to solve one of the biggest limitation in the ...

Phase II study of eribulin with trasutuzumab for pretreated locally advanced or metastatic HER2-positive breast cancer. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This ...

Tissue biopsies with tumor cell contents that are too low for conventional testing methods can now be rescued due to the ability of MSB's DEPArray technology* to successfully recover low numbers of ...

Genetic Profiles of Circulating Tumor Cells May Predict Drug Resistance and Clinical Outcomes BOLOGNA, Italy, and SAN DIEGO, Nov. 25, 2016 /PRNewswire/ --Menarini-Silicon Biosystems today announced ...

Tissue biopsies with tumor cell contents that are too low for conventional testing methods can now be rescued due to the ability of MSB's DEPArray technology* to successfully recover low numbers of ...